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In situ hybridization and immunohistochemistry were used to determine the spectrum of tissues
in which interleukin-2 (IL-2) mRNA and protein are found in healthy, normal young mice. In
neonatal animals, IL-2 is expressed specifically by distinct, isolated cells at three major sites: the
thymus, skin, and gut. Based on morphology and distribution, the IL-2-expressing cells resemble
CD3e T cells that are also present in all these locations. Within the thymus of postweanling
animals, both TcRafl and TcR),6 lineage cells secrete "haloes" of the cytokine that diffuse over
many cell diameters. Within the skin, isolated cells expressing IL-2 are seen at birth in the
mesenchyme, and large numbers of IL-2-expressing cells are localized around hair follicles in
the epidermis in 3-week-old animals. At this age, a substantial subset of CD3 cells is similarly
localized in the skin. Significantly, by 5 weeks of age and later when the CD3e cells are evenly
distributed throughout the epidermis, IL-2 RNA and protein expression are no longer detectable.
Finally, within the intestine, IL-2 protein is first detected in association with a few discrete,
isolated cells at day 16 of gestation and the number of IL-2 reactive cells increases in frequency
through El9 and remains abundant in adult life. In postnatal animals, the frequency of IL-
2-positive cells in villi exceeds by greater than fivefold that found in mesenteric lymph node or
Peyer’s patches. Overall, these temporal and spatial patterns of expression provide insight into
the regulation of IL-2 in vivo and suggest a role for IL-2 expression distinct from immunological
responses to antigen.
Keywords: Dendritic epidermal T cells, gut-associated lymphocytes, TCR-yt3 thymocytes, TCR-a/3
thymocytes, in situ hybridization, immunohistochemistry, developmental regulation, interleukin-2
INTRODUCTION
Interleukin-2 (IL-2) has been best studied as a growth
factor secreted by activated T cells in the course of the
immune respohse. Its expression is strictly dependent
on inducing stimuli, with requirements forseparate
signals from Ca+2-dependent, ras-dependent, and
*Corresponding author.
possibly additional signaling pathways (Jain et al.,
1995; Serfling et al., 1995). These requirements are
met in mature T cells when they encounter antigen on
antigen-presenting cells, thereby delivering coordi-
nated signals triggered by the crosslinking of TcR/
CD3 complexes, CD4 (or CD8 in some cases), and
CD28. Accordingly, analysis of the cis and trans
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regulatory elements critical for IL-2 expression has
shown several discrete protein-DNA interactions that
require activation by TcR/CD3- and/or CD28-
dependent signaling mediators (Jain et al., 1995;
Serfling et al., 1995). The observation that IL-2 is also
expressed primarily or exclusively by T cells has led
to a general assumption that the primary function of
IL-2 expression in vivo is to regulate T-cell clonal
expansion as triggered by T-cell recognition of
foreign antigen.
This assumption has been challenged in recent
years by the phenotype of IL-2 "knockout" mice.
Animals homozygous for targeted disruption of the
IL-2 gene show initially normal numbers of T cells of
various subsets and detectable but relatively subtle
defects in their immediate proliferative responses to
antigen (Schorle et al., 1991; Ktindig et al., 1993;
Krimer et al., 1994; Cousens et al., 1995; Kneitz et
al., 1995). By contrast, multiple aspects of their long-
term hematopoietic regulation and lymphocyte
homeostasis are disrupted (Sadlack et al., 1993, 1995;
Krimer et al., 1995; Reya, 1996).
These findings raise several questions about the
role of IL-2 expression in vivo. First, is IL-2
expressed in homeostatic contexts as well as in acute
immune responses? Second, does IL-2 expression
regulate hematopoietic populations in nonlymphoid
tissues? Lastly, is mature cell behavior affected by
prior exposure or lack of exposure to IL-2 during
development? In order to address these questions, we
systematically examined various organs of normal
young mice to determine where IL-2 is detectably
expressed. Our studies show that IL-2 mRNA and
protein are associated with specific tissues in situ.
These tissues invariably contain T cells, suggesting
that IL-2 may be involved in regulating lymphocytic
and/or hematopoietic function(s) at these sites.
RESULTS
Overall Distribution of IL-2-Expressing Cells in
Neonatal Mice
To survey the range of tissues that might express the
IL-2 gene in mice, neonatal mouse body sections were
analyzed by in situ hybridization with 35S-labeled
probes. The results of these analyses showed that
most tissues of the body were devoid of hybridization
above background, as established with sense-strand
control probes. Brain, heart, lung, liver, stomach,
bladder, and other parts of the body showed no
evidence of IL-2 mRNA at this time (Yang-Snyder,
1994; data not shown). However, cells appearing to
express IL-2 were seen reproducibly in three distinct
domains: (1) the thymus, (2) the dermal region of the
skin, and (3) the intestine. In neonatal animals, the
intrathymic IL-2-producing cells appeared as individ-
ually labeled cells located predominantly in the inner
cortical region, as described previously (Yang-Snyder
and Rothenberg, 1993). In the skin and gut, cells
expressing IL-2 mRNA appeared as discrete, round
cells, as shown in Figures I(A) to I(C) (and data not
shown). Most IL-2-expressing cells in the skin were
located within the mesenchyme, and IL-2-expressing
cells in the intestine were found in the lamina propria
of the villi. IL-2 protein was also readily detectable in
the thymus and gut of neonatal animals (see what
follows). Due to technical difficulties, the presence of
IL-2 protein in the skin was not determined. Alto-
gether, these data demonstrate that IL-2 mRNA and
protein are found in specific lymphoid and non-
lymphoid tissues in healthy, normal neonatal mice.
IL-2-Expressing Cells in Tissues of Weanling
Mice
Based on these findings described IL-2 expression in
the thymus, skin, and intestine of older animals was
examined. In situ hybridization of isolated tissues
from older weanling mice (3-4 weeks after birth)
revealed that IL-2 mRNA cells continued to be
detected in the thymus, skin, and gut (Yang-Snyder
and Rothenberg, 1993; Figure 2 and data not shown).
Likewise, IL-2 protein was also detected in these
tissues at this stage (Yang-Snyder and Rothenberg,
1993; Figures 3 and 4). IL-2 expression in the thymus
and gut remained relatively similar to that seen in
neonatal animals, whereas IL-2 expression in the skin
exhibited a marked spatial pattern of expression that
changed according to the developmental age. These
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Importantly, the IL-2-reactive "zones" were specific,
as this staining was blocked by an excess of
recombinant murine IL-2 [Figure 5(D)]. These data
suggest that IL-2 secreted by individual cells can
diffuse over many cell diameters in vivo, and that a
prefixation step allows this extracellular IL-2 to be
retained and detected as immunoreactive zones.
Many of the immunoreactive zones were found at
the cortical-medullary border or apparently within the
medulla, where the most mature thymocytes are
concentrated. Furthermore, no extensive zones of IL-
2 immunoreactivity were detected in thymi taken
from SCID or RAG-2-/- mice that lack TcR cells,
even with prefixation (data not shown). This finding
raises the possibility that cells responsible for secret-
ing the large haloes of IL-2 are relatively mature TcR
thymocytes. To test this interpretation, immunohis-
tochemical staining was performed on sections of
thymic tissue from mice homozygous for targeted
disruptions in one or more TcR genes, in which
development of the cq3-TcR and/or y-TcR lineage
is blocked at characteristic checkpoints. These lesions
cause significant organizational changes in the thy-
mus, as shown in Figure 6. Disruption of TcRce
interferes with positive selection of cq3-TcR T cells
and suppresses formation of the medulla, as revealed
by the absence of regions of decreased cellularity
within the thymus [Figure 6(A)]. On the other hand,
disruption of TcR/3 blocks an early stage in the
development of cq3-TcR cortical thymocytes and
essentially eliminates the normal structure of the
densely populated thymic cortex, yielding a relatively
uniform distribution of cells within the thymus and
reduced organ size [Figure 6(B)]. Disruption of TcR6
eliminates the minority T3-TcR lineage and has less
obvious effect on overall thymic architecture and size
[Figure 6(C)]. Finally, disruption of both TcR/3 and
TcR genes blocks the generation of both cq3- and T6-
TcR T cells, yielding a greatly shrunken organ [even
more so than that observed in TcR/3-/- animals;
Figure 6(D)].
Although the structural context varied depending
on the stage at which thymocyte development and/or
maturation was blocked, zones of IL-2 immuno-
reactivity were observed in thymi taken from animals
homozygous for disruption of any single TcR gene
[Figures 6(A) to 6(C)]. However, zones of extensive
IL-2 protein diffusion were absent in the thymi of
mice with disruptions in both the TcR/3 and TcR6
genes [Figure 6(D)], in good agreement with the data
obtained using SCID and RAG-2-/- mice (data not
shown). Thus, the production of large amounts of
secreted IL-2 protein in the thymus depends on the
maturation of at least one lineage of TcR thymo-
cytes, but the presence of either cq3- or T6-TcR cells
could suffice.
Variable Persistence and Localization of IL-2-
Expressing Cells in Nonthymic Tissues of
Postnatal Mice
As mentioned previously, IL-2-expressing cells asso-
ciated with the skin were found predominantly in the
underlying mesenchyme in newborn mice. However,
at 3 weeks of age, IL-2 mRNA cells in the skin were
observed in large clusters, as shown by in situ
hybridization to ear epidermal sheets [Figure 2(A);
data not shown], and appeared to be associated with
hair follicles [residual hair shafts were observed in
some fields, or round pigmented "pits" in others, as
indicated by arrowheads in Figure (2)]. Notably, this
expression did not persist at stable levels into later
life. By 5 weeks of age, IL-2 RNA was no longer
detectable in such clusters [Figure 2(C)], and
remained undetectable at least through 14 weeks of
age [Figure 2(E)]. Concordant with the mRNA
detection, numerous IL-2 immunoreactive clusters
were seen in ear epidermal sheets at 3 weeks of age,
but decreased markedly by 5 weeks of age, and were
not readily detected at all at 14 weeks of age (Figure
3). The observed staining was shown to be specific, as
preincubation of the primary antibody with recombi-
nant-derived murine IL-2 abolished staining alto-
gether (data not shown). The absence of immuno-
reactive clusters in epidermal sheets taken from older
animals could not be attributed to a problem with
retaining immunoreactive protein in the samples,
since prefixation of ear epidermal sheets in paraf-
ormaldehyde did not increase the sensitivity of
staining in samples taken from mice at any age (data
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TABLE Frequencies of IL-2-Reactive Cells Detected by Immunohistochemical Staining of Normal Small and Large Intestine
Sections
Sample Number of IL-2 cells Number of nuclei counted Percentage of IL-2 cells
Small intestine (villi): 3 weeks
Large intestine: 3 weeks
Small intestine (villi): 3 months
Large intestine: 3 months
Peyer’s patch: 3 months
Mesenteric lymph node: 3 months
220 9544 2.3
112 9451 1.2
429 9629 4.5
121 9378 1.3
47 5883 0.7
22 3505 0.6
"Following immunohistochemical staining, sections were counterstained with DAPI. Nuclei were visualized under fluorescence microscopy.
Random fields at 200 magnification were analyzed to remove bias toward positively staining areas. No immunoreactive cells were
observed in negative control stainings of serial sections.
not shown). Thus, the expression of IL-2 by isolated
cells in the dermis of neonates appears to progress to
synchronous secretion of IL-2 by clusters of epi-
dermal-associated cells at 3 weeks of age, followed by
a shutoff of IL-2 expression in subsequent weeks.
In the intestinal tract, expression of IL-2 persisted
in a stable pattern in neonates and older animals
(Figure 4). Although isolated positive cells were
observed by in situ hybridization of intestine samples
taken from postweanling mice using 35S-labeled
probes, nonspecific background as determined with
the sense-strand control probe also increased signifi-
cantly after birth (data not shown). Additionally, IL-2
protein was difficult to detect in the gut using
conventional fresh-frozen sections (data not shown),
but sensitivity of staining was enhanced greatly by
prefixation of the tissue in paraformaldehyde (Figure
4). In neonatal animals, the percentage of cells
positive for detectable IL-2 protein was always
significantly higher (--20-fold) than the cells with
detectable IL-2 mRNA (data not shown). This did not
reflect a lack of specificity in the immunohistochem-
ical staining, but rather the increased persistence of
the IL-2 protein as compared to the mRNA within the
cell of origin and/or when associated with IL-
2-binding target cells.
In weanling and postweanling animals, cells in both
the small and large intestine were found to be
immunoreactive to IL-2 antibody at relatively con-
stant frequencies from 3 weeks to 3 months of age
(Figure 4). In these young adult animals, most
intestinal staining was observed in lamina propria-
associated cells as opposed to intraepithelial cells.
Once again, the specificity of this staining was shown
by antibody blocking using recombinant-derived
murine IL-2 (Figure 4, right-hand panels). The
frequency of IL-2 immunoreactive cells in the lamina
propria was actually higher than the frequency of
positive cells found in specialized lymphoid tissues,
such as Peyer’s patches and mesenteric lymph nodes
(see Table 1), indicating that IL-2 expression in the
gut is found predominantly in "nonlymphoid" sites in
the gut.
Association of IL-2 Expression with the Presence
of Mature T Cells in the Skin and Gut
In the thymus, the vast majority of cells are within the
T-cell developmental lineage, and the morphology of
IL-2 RNA cells as already reported indicates that
these cells are part of the T-lineage majority rather
than part of the minority of morphologically distinct
stromal cells (Yang-Snyder and Rothenberg, 1993).
T-lineage cells from the skin and gut have also been
shown to express IL-2 when activated by immuno-
logical stimuli (Gramzinski et al., 1993; Matsue et al.,
1993b; Guehler et al., 1996; Lundqvist et al., 1996)
However, the connection between the developmental
patterns of IL-2 production observed in these tissues
and the presence of T cells remained to be defined. To
determine whether IL-2 producers might colocalize
with T cells in the skin and gut, ear epidermal sheets
and gut sections were stained for the expression of T-
cell markers.
In the skin, the distribution of IL-2 producers in
follicle-associated clusters did not obviously correlate
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with any previous report of dendritic epidermal T-cell
distribution (Miyauchi and Hashimoto, 1989; Payer et
al., 1991; Elbe et al., 1992), albeit the sharp age
dependence of the clustered IL-2 expression raised
the possibility that T-cell distribution at this critical
time point had not been examined. Therefore, immu-
nohistochemical staining analyses were carried out
using an antibody specific for the invariant CD3e
component of the TcR. Staining of ear epidermal
sheets from 5-week-old mice with anti-CD3E yielded
a familiar dendritic pattern (data not shown), but at 3
weeks of age, clusters of heavily stained cells as well
as the expected "dendritic" pattern were observed
[Figure 7(E)]. The distribution of CD3e staining was
not due to an epidermal organization artifact, since it
was highly dependent on age and the presence of
mature T cells (see what follows). Importantly, this
pattern resembled markedly the pattern of IL-2
protein expression in ear epidermal sheets at the same
time [Figure 7(G)]. It should also be noted that
occasional, isolated IL-2 mRNA cells with dendritic
morphology were observed in ear epidermal sheets at
3-4 weeks after birth (data not shown). Side-by-side
in situ hybridization and CD3e staining of single ear
epidermal sheets taken from 3-week-old mice
revealed that when maximal IL-2 expression was
observed in this tissue, IL-2 mRNA clusters were
associated with greater than 60% of hair follicles, and
up to 75% of hair follicles had concomitant CD3e
clusters (data not shown). The coincident staining of
CD3e and IL-2 in follicle-associated clusters was not
due to general trapping of antibodies in these
structures. Parallel epidermal sheets stained for IL-2
protein and for the IL-2 receptor ce chain (CD25)
showed no CD25 immunoreactivity at all, even under
conditions where staining of CD25 cells in fetal
thymus was readily detected (Figure 8). Therefore,
significant overlap can exist between the distribution
of IL-2-expressing cells and CD3e cells in the skin at
3 weeks of age, suggesting that the dense clusters of
IL-2-expressing cells likely contain substantial num-
bers of CD3e cells.
CD3e cells in the gut were also readily detected in
the regions where IL-2-expressing cells were found.
The percentage of CD3e cells of all classes was
found to be modestly higher than the percentage of
cells staining for IL-2 protein in any given domain
(7.3% and 3.5% CD3e cells in the small and large
intestine, respectively, as compared with 4.5% and
1.3% IL-2 protein-positive cells in these domains at 3
months of age), and at least 20-fold higher than the
percentage of cells with IL-2 RNA (data not shown).
Both TcRcq3- and TcRy6-positive subsets were
present, with CD8ce-positive cells present at 50-70%
the frequency of CD3e cells overall (Yang-Snyder,
1994). It should be noted that due to the ambiguity in
distinguishing IL-2-expressing cells from IL-2-bind-
ing cells by this assay, it was not possible to further
define the relationship between IL-2 production and
CD3e expression in this region.
Dependence of in vivo IL-2 Expression on the
Presence of Mature Lymphocytes
To test whether skin- and gut-associated T cells might
be required for the spontaneous expression of IL-2 in
vivo, wild-type mice were compared with immunode-
ficien SCID mice that lack mature T or B cells, due
to a defect in double-stranded DNA break repair
required for the completion of successful TcR and Ig
gene rearrangement (Bosma and Carroll, 1991). With
respect to all other cell lineages, SCID animals are
normal, and they remain fertile and healthy overall. In
the skin, the scid mutation blocked the appearance of
IL-2-expressing cells (Figure 9). Both IL-2 mRNA
[Figure 9(C)] and IL-2 protein [Figure 9(E)] were
undetectable in ear epidermal sheets from 3-week-old
SCID mice. Likewise, clusters of CD3e cells are
conspicuously absent in the mutant samples [Figure
9(A)], supporting the identification of these novel
assemblages in the skin of normal mice as clusters of
mature T cells. These data reveal a strong correlation
between IL-2 expression and the presence of mature T
cells in the skin.
Similar observations were made for IL-2
expression and the presence of mature T cells in the
gut. In contrast to neonatal wild-type gut, IL-2
mRNA cells could not be found in the neonatal SCID
gut [Figures 10(A) and 10(B)]. With regard to protein
production, the SCID gut was also deficient [Figures
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Precocity of "Spontaneous" IL-2 Expression in
the Gut
The presence of IL-2 in these tissues raises questions
about its functional significance in the context of the
stimuli that induce it. Several possibilities can be
envisioned. Since IL-2 expression appears tightly
associated with the presence of mature T cells and
most of the animals studied here were not maintained
under sterile conditions, it is possible that the
induction of IL-2 expression occurs as part of a
conventional immune response. Additionally, since
IL-2 is a pleiotropic cytokine with receptors
expressed on a variety of cells, including intestinal
epithelial cells (Ciacci et al., 1993; Reya, 1996; Reya
et al., 1996), IL-2 expression could participate in
conditioning the microenvironment, thereby perform-
ing a role mandated more, perhaps, by developmental
cues than by acute immunological challenge. Finally,
since IL-2 is a potent growth factor, IL-2 may play a
role in the expansion of T-cell populations, again in a
way that might respond to homeostatic population
maintenance signals (Rocha et al., 1989) rather than
to contact with a foreign antigen.
To help address some of these questions, we
examined tissues from mice that had not yet left the
womb and could not yet have begun to feed. In such
animals, IL-2-expressing cells were not easily
detected in the skin (data not shown; see Discussion).
However, IL-2 protein was observed in the gut of
older fetal animals (day 19-20 of gestation), as shown
in Figure 11(A). "Nests" of cells staining positively
for IL-2 protein were already concentrated within
villi. To establish how early IL-2 might be found in
the gut, tissue from younger fetal animals was
analyzed in parallel. By day 16 of gestation, rare IL-2
immunoreactive cells were already present in the gut,
as shown in Figure 11 (B), albeit at a frequency (0.3%)
that was about tenfold lower than the frequency at day
19-20 of gestation. Although the origin of these IL-2
producers is not clear, we have previously shown that
cells staining strongly for IL-2 protein are present in
the fetal liver and omentum as well as the fetal
thymus by day 15 of gestation (Reya et al., 1996). Our
results suggest that some of the first lymphoid cells
immigrating to the fetal gut may be induced to
express IL-2 even while in transit. The precocious
onset of IL-2 expression in these populations of fetal
cells suggests that IL-2 expression is widely induced
by developmental cues and not solely by "immuno-
logical" responses to encounter with foreign anti-
gens.
DISCUSSION
The results presented here show that cells are induced
to express IL-2 in at least three distinct sites in the
young mouse in vivo: the thymus, skin, and gut. The
regulation of IL-2 expression as a function of
developmental state and presumed stimulus varies at
each site. Significantly, IL-2 expression in these sites
is correlated with the presence of mature lympho-
cytes, and more particularly with T cells. In contrast,
IL-2 RNA and protein are not readily detected in any
tissue parenchyma or in the brain, providing further
evidence for the general T-cell specificity of IL-2
expression.
An unanticipated feature of the pattern of
expression is the abundance of IL-2 production in
contexts where the stimulus is unlikely to be a foreign
antigen. In addition to the ongoing expression of IL-2
by cells within the thymus, we document two further
cases where responses to exogenous antigen or to any
clonotypic stimulus seem unlikely to explain the
control of IL-2 expression. One case is the skin,
where lymphoidlike cells deep in the mesenchyme
appear to express IL-2 within hours of birth, and
whole clusters of cells later secrete high levels of IL-2
until between 3 and 5 weeks of age, when IL-2
expression stops abruptly. Whatever the trigger for
the shutoff, there is no straightforward way to
correlate the domains and stages in which IL-2 is
expressed by these cells with putative exposure to an
environmental antigen. The other case is the intestine,
surely a site of exposure to environmental antigens in
postnatal life. However, IL-2 expression in the gut
first appears at El6 and persists from this point
onward; hence, environmental antigen derived from
feeding cannot be responsible for stimulating the
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these primitive fetal cell types, does persist in the
adult thymus as well (Hua Wang and E.V.R.,
unpublished results). Thus, these cases of frankly
TcR-independent IL-2 induction set a precedent for
the potential polyclonal induction of IL-2 expression
by developmentally staged environmental stimuli.
Outside the thymus, IL-2 production appears to be
associated with the presence of mature T cells. The
mature T cells in the skin and gut of young mice are
likely to have distinct origins. Both appear different
from the common circulating pools of T cells that
populate the spleen and lymph nodes, where in fact
we do not detect significant spontaneous IL-2
expression (data not shown). The T-cell population in
the skin is heterogeneous, composed of a major
subpopulation of yS-cells of known origin and a
minor one of o/? cells of unknown lineage. The
predominant lineage arises from a unique Vy3(5)
class of fetal thymocytes that are generated in a single
wave, starting at about El5, and emigrate from the
thymus at about E16-17 (Havran and Allison, 1990;
Allison, 1993; Haas et al., 1993). As mentioned
previously, these cells share a single invariant TcR
with a uniform recognition specificity (Havran et al.,
1989). This lineage ,may have an unusually high
sensitivity to IL-2, since it is preferentially expanded
in fetal thymocyte populations that are cultured in the
presence of high doses of IL-2 (Leclercq et al., 1990,
1992) and its development is especially sensitive to
inhibition by antibodies against the IL-2-receptor /3
chain (CD122) (Tanaka et al., 1992). In contrast, T
cells entering the gut in fetal life may also be
dominated by the use of a single Vy segment
IVy5(7)] (Carding et al., 1990; Haas et al., 1993), but
the junctions and recognition specificities of their TcR
are quite diverse. At least some of these cells are
thought to be of extrathymic origin, but postthymic
cells and cells apparently generated in situ contribute
to the population, and may continue to seed the gut
throughout life (Rocha et al., 1994; Lefrancois and
Puddington, 1995).
What T cells in the skin and gut have in common is
a requirement for extensive postthymic or extra-
thymic expansion preceding their role in immune
surveillance. The total number of these cells that is
generated initially can be very small. At the sole time
in gestation when Vy3(5) cells are generated as a
small subset of thymocytes, the whole fetal thymus
contains only -105 cells. Therefore, in order to
populate the whole epidermis at a density of approxi-
mately 6-8 102 cells/min2 in the adult animal,
extensive extrathymic expansion of the V),3(5) cells
is required. IL-2 expression could be a part of a
general growth-stimulating program that is utilized by
this population to reach the needed cell density in the
huge target organ. For the gut-associated lymphocyte
population, there is probably continuing cellular
input. Even so, the expression and production of IL-2
begins as early as the arrival of the first lymphoid-
appearing cells in the gut, and the frequency of IL-2
protein-positive cells increases tenfold over the next 3
days of gestation. The earliest stages when IL-
2-positive cells are seen in the gut is concurrent with
the appearance of IL-2-producing cells observed
previously in the fetal omentum (Reya et al., 1996;
data not shown). Thus, IL-2 expression, or a general
cytokine production program of which IL-2
expression is a part, may coincide with an initial
period of seeding and expansion of T lymphocytes in
the fetal gut. Confirmation that some cytokine-driven
growth program is essential for the expansion of both
cell types comes from the complete elimination of
IEL and DETC as well as natural killer cells in mice
with a disrupted common cytokine-receptor yc gene,
or with a disrupted JAK3 kinase gene that is used for
cytokine-receptor signal transduction (Cao et al.,
1995; DiSanto et al., 1995; Park et al., 1995).
IL-2 itself is not required as a unique growth factor
for either dendritic epidermal T cells or gut-associated
lymphocytes, since these populations are found in
mice homozygous for a disrupted IL-2 gene. Pre-
liminary observations indicate that IL-2-deficient
mice may even possess close to normal densities of
CD3e cells in the skin as early as weaning age (J.A.
Y-S., unpublished results). The apparently normal
generation of skin T cells in the absence of IL-2 can
be attributed to their ability to proliferate in response
to other cytokines, IL-7 and IL-15, which can be
secreted by keratinocytes (Matsue et al., 1993a;
Edelbaum et al., 1995). However, the simple presence
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of these cells does not prove that they are functionally
normal. Moreover, the disruption of the IL-2 gene
leads to significant dysfunction in the gut and chronic
inflammatory bowel disease, which contribute to the
early mortality observed for IL-2-deficient mice
(Sadlack et al., 1993). The basis for this dysfunction is
still under investigation, but it may be a result of the
incomplete redundancy of functions of cytokines that
share some but not all effects of IL-2 on target
populations. There is evidence that IL-2 can partici-
pate directly in several kinds of autocrine or paracrine
growth-stimulatory loops in the intestinal milieu
throughout life (Ciacci et al., 1993; Gramzinski et al.,
1993; Fujihashi et al., 1996), and perhaps also play a
role in restricting excessive lymphocyte activation
(Kneitz et al., 1995). Thus, the regulation of IL-2
expression in vivo, whether "immunological" or
"nonimmunological," cannot be dismissed as func-
tionally insignificant. The possible induction of IL-2
by nonimmunological signals raises fascinating ques-
tions of molecular mechanism for future study.
In conclusion, our studies raise the possibility that
IL-2 expression in vivo might be controlled pre-
dominantly by signals not emanating from the
clonotypic TcR. Though IL-2 gene regulation is
perhaps the best studied of all lymphocyte responses
to antigen stimulation (Jain et al., 1995; Serfling et al.,
1995; Rothenberg and Ward, 1996) and the transcrip-
tion factors that service the minimal enhancer of the
IL-2 gene are now securely associated with termini of
known signaling pathways emanating from the TcR/
CD3 and CD28 cell-surface receptors, the results
presented here suggest that additional activation
mechanisms exist that may be as fundamental for the
overall biological role of IL-2 as are the familiar ones
used in the "classical" immune response. From a
molecular standpoint, it will be of great interest to
determine the cell-surface receptor-ligand interactions
responsible for inducing IL-2 expression in vivo and
whether novel cis and trans regulatory elements are
involved in regulating IL-2 expression. On a cellular
level, further characterization of IL-2-producing and
IL-2-responsive cells will undoubtedly increase
understanding of such "nonimmunological" functions
of IL-2 in vivo.
MATERIALS AND METHODS
Mice
C57BL/6 Tla mice, transgenic mice with an cq3-TcR
specific for H-2Ld (Sha et al., 1988), and C.B-17-scid
(SCID) mice were bred and maintained in our own
facility. The SCID breeders were carefully selected to
maintain a particularly low level of "leakiness" in
their progeny, as described previously (Rothenberg et
al., 1993). All SCID animals were maintained in an
Isotec flexible film isolator (Indianapolis, IN) with
autoclaved food, water, and bedding, but without
antibiotic treatment. 2C cq3-TcR transgenic animals, a
generous gift from William Sha and Dennis Loh, were
rederived to be virus-free by embryo transfer, back-
crossed to either B10 (Jackson Laboratories, Bar
Harbor, ME) or B 10.S (Charles River Laboratories,
Willmington, MA) genetic backgrounds, and kept on
sterile food and bedding. Regular monitoring of our
colony verified that animals used were pathogen-free
(data not shown). Neonatal animals were taken within
12 hr after birth. Fetal tissues were taken from fetuses
removed from pregnant BL/6 Tla and SCID mothers
using timed matings. The appearance of a vaginal
plug was designated as day 0.
Removal and Processing of Tissues
Activated lymph node and fetal thymus samples were
prepared as described in (Yang-Snyder and Rothen-
berg, 1993). "Adult" thymi were removed from
3-5-week-old weanling animals. Intestinal samples
from adult animals were extensively flushed with cold
phosphate buffered saline (PBS) before processing.
For in situ hybridization or detection of cell-surface
antigens, separated tissues and freshly decapitated
neonatal body samples were washed thoroughly in
cold PBS, blotted dry, immediately embedded in
Tissue-Tek O.C.T. compound (Miles Laboratories,
Kankakee, IL), and flash frozen on dry ice. If samples
were not sectioned immediately, they were first stored
at -80C. Eight-/zm cryosections were collected onto
poly-L-lysine-coated slides, air dried briefly, and
fixed in freshly made 4% paraformaldehyde in PBS
for 10 min on ice. Following a wash in cold PBS,
242 JULIA A. YANG-SNYDER and ELLEN V. ROTHENBERG
slides were air dried completely and stored with
desiccant at -80C prior to hybridization. At least 12
hr before hybridization, slides were thawed, trans-
ferred to 70% ethanol, and kept at 4C.
For detection of extracellular as well as intra-
cellular IL-2 protein, organs were prefixed in 4%
paraformaldehyde for 1-2 hr on ice prior to embed-
ding. Following fixation, organs were thoroughly
washed with cold PBS, saturated in 30% sucrose in
PBS, and embedded in O.C.T. To correlate IL-2 and
cell-surface staining of intestinal samples taken from
older animals, 3-5-mm pieces of intestine were cut in
half; one-half was embedded directly in O.C.T. and
the other was prefixed in paraformaldehyde solution
before embedding. Following cryosectioning, both
unfixed and fixed samples were soaked in acetone for
20-30 min at room temperature, air dried, and stored
with desiccant at -80C.
For preparation of ear epidermal sheets, ears were
collected and hair was removed by shaving or using a
hair-removal wax strip kit (Sally Hansen/Del Labora-
tories Inc., Farmingdale, NY). Shorn ears were then
floated on 0.5 M ammonium thiocyanate (SIGMA, St.
Louis) in 0.1 M phosphate, pH 6.8, and incubated at
37C for 10-15 min. The outer epidermis was
separated from the underlying tissue and washed
immediately in cold PBS. Whole ear epidermal sheets
from the same age animals were used as pairs in all in
situ hybridization experiments, with one hybridized to
the antisense probe and one to the sense-strand
control probe. For the modified "whole-mount" in situ
hybridization procedure, unmounted epidermal sheets
were fixed in 4% paraformaldehyde solution as
before, then dehydrated in graded ethanols prior to
storage in 70% ethanol at 4C. For immunohis-
tochemistry and immunofluorescence, epidermal
sheets were air dried onto coated slides, fixed in
acetone at room temperature for up to hr, and
rehydrated immediately in PBS and stained.
Hybridization Probes
Either 410- or 590-nucleotide (nt) IL-2 antisense or
sense RNA probes were used as described (Yang-
Snyder and Rothenberg, 1993). Details for the
synthesis of 35S-labeled transcripts are given else-
where (McGuire and Rothenberg, 1987; McGuire et
al., 1988). In vitro transcription of digoxigenin-
11-UTP (dig)-labeled RNAs was carried out accord-
ing to the manufacturer’s specifications (Boehringer
Mannheim Biochemicals, Indianapolis, IN; Ransick
et al., 1993). Transcription products were resuspended
in 200/zl of 100 mM DTT and 0.1% SDS and stored
at -80C. 35S-labeled transcripts were used within a
week and dig-labeled probes were used up to 6
months after synthesis.
In Situ Hybridization Using 3sS-Labeled Probes
Whole body and isolated tissue sections were hybrid-
ized to S-probes, as described in Yang-Snyder and
Rothenberg (1993). Hybridized sections were
dehydrated in graded ethanols containing 0.3 M
ammonium acetate, dipped twice in NT-2B Nuclear
Track Photographic Emulsion (Eastman Kodak,
Rochester, NY), and air dried in a lighttight box at
room temperature. Slides were then transferred to a
plastic VWR slide box containing drierite, and
exposed for 14-21 days at 4C. Slides were developed
at 12-13C, coverglasses mounted, counterstained
with hematoxylin and eosin, mounted with cover-
glasses, and analyzed by bright and dark field
microscopy.
"Whole mount" In Situ Hybridization of Ear
Epidermal Sheets using Digoxigenin-Labeled
Probes
An alternative "whole mount" procedure (Ransick et
al., 1993) was adapted for ear epidermal sheets.
Unmounted epidermal sheets were rehydrated
through graded ethanols, washed in PBS containing
0.1% Tween-20 (PBST), and digested lightly in 2/g/
ml proteinase K in PBS for 2-4 min at room
temperature. Samples were transferred to glycine,
refixed in 4% paraformaldehyde in PBS for 20 min at
room temperature, rinsed briefly in PBS, and acety-
lated with 0.3% acetic anhydride in 0.1 M triethanola-
mine, pH 7. Following another PBST wash, samples
were soaked in 0.1 M Tris-glycine, pH 7.4 for 30 min,
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rewashed in PBST, and prehybridized in hybridiza-
tion buffer (50% deionized formamide, 10% PEG-
8000, 600 mM NaC1, 20 mM Tris-HC1, pH 7.4, 5 mM
EDTA, 500/xg/ml yeast tRNA, 2X Denhardt’ s, 0.1%
Tween-20, 20 mM CHAPS, and 10 mM vanadyl
ribonucleoside complexes) for 3-4 hr at 37C. In the
meantime, dig-labeled RNA probes were briefly
hydrolyzed in carbonate buffer (60 mM NazCO3, 40
mM NaHCO3, pH 10.2) for 2-3 min at 60C, quickly
transferred to an ice bath, and neutralized with an
equal volume of 200 mM sodium acetate, 1% acetic
acid (v/v), pH 6.0. Probes were then ethanol-
precipitated, resuspended in a solution of 20 mg/ml
yeast tRNA (500/xg tRNA per/xg probe), denatured
by heating for 7-10 min at 95C, and then added
directly to fresh hybridization buffer to a final
concentration of 0.05-0.1 ng/ml hydrolyzed probe.
Following prehybridization, samples were rinsed in
PBST and transferred immediately to a hybridization
buffer-containing probe. Hybridization was carried
out for 12-15 hr at 42C. The ensuing day, samples
were washed twice in PBST, once at room tempera-
ture and then at 37C, and digested in 100 /xg/ml
RNase A in PBS for 20 min at 37C. After RNase
digestion, samples were washed in PBS at 37C, 1X
SSC at 45C, 0.1X SSC at room temperature, and
finally in PBST at room temperature. All post-
hybridization washes were carried out for at least 30
min with agitation.
For detection of dig-labeled probe, samples were
blocked in 5% goat serum in PBST for 30-60 min at
room temperature and then incubated in a 1:200
dilution of alkaline phosphatase-conjugated sheep
anti-dig Ab, Fab fragment (Boehringer Mannheim
Biochemicals) in PBST containing 5% goat serum
and 5% mouse serum for 1-3 hr at room temperature.
Samples were subsequently washed several times in
PBST for at least 2 hr at room temperature with
shaking, twice briefly in Tris-buffered saline +0.1%
Tween-20 (TBST) and twice in alkaline phosphatase
buffer (100 mM Tris-HC1, pH 9.5, 50 mM MgCI2,
0.1% Tween-20, mM levamisole). Stained samples
were developed in alkaline phosphatase buffer con-
taining 338/xg/ml nitro blue tetrazolium and 175/xg/
ml 5-bromo-4-chloro-3-indolyl phosphate (NBT and
X-phosphate, respectively; both from Boehringer
Mannheim Biochemicals) for 3-4 hr at room tempera-
ture in the dark. Colorimetric reactions were mon-
itored periodically to avoid overdevelopment and
stopped by transferring samples to PBST + mM
Na2EDTA. Samples were finally dehydrated in graded
ethanols, transferred to 2-propanol, cleared in
xylenes, and mounted onto glass slides under cover-
glasses and observed under bright field microscopy.
Antibodies
Rat anti-mouse IL-2 mAb ($4B6), phycoerythrin
(PE)-conjugated anti-mouse cq3 TcR mAb (H57), and
biotinylated hamster anti-mouse CD3e (500.AA2 and
145-2Cll) and T6TcR (GL3) mAbs were purchased
from Pharmingen (San Diego). Fluorescein (FITC)-
conjugated hamster anti-mouse CD3e (145-2Cll)
was obtained from Boehringer Mannheim Biochem-
icals and. biotinylated rat anti-mouse CD8ce from
Becton-Dickinson (Mountain View, CA). Biotiny-
lated rat anti-mouse CD4 (H129.19) was purchased
from GIBCO/BRL (Gaithersburg, MD). Biotinylated
secondary reagents, rabbit anti-rat IgG and goat anti-
hamster IgG, both mouse absorbed, were obtained
from Vector Laboratories (Burlingame, CA) and
CALTAG Laboratories (San Francisco), respectively.
Normal rat IgG was reconstituted at a concentration
of 20 mg/ml (Miles Laboratories) and normal mouse
serum at 60 mg/ml (Cappel/Organon Teknika Corp.,
West Chester, PA). Recombinant mouse IL-2 was
purchased from Genzyme (Boston).
Immunohistochemistry and Direct
lmmunofluorescence Staining
Protocols for immunohistochemical and immuno-
fluorescence staining of nonprefixed sections were
followed as given in Yang-Snyder and Rothenberg
(1993), except that the avidin-biotin blocking step
was omitted, all antibody incubations were carried out
overnight at 4C, and washes were increased to 1-2 hr
at 4C. For staining of prefixed sections to detect IL-
2, sections were thawed, rehydrated in PBS, postfixed
briefly in 1% formaldehyde in PBS for 1-2 min at
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room temperature, and washed in PBS and incubated
in PBST for 30 min at room temperature. Sections
were then blocked in PBS/I% BSA, Fraction V/0.1%
NaN3 for 1-2 hr at 4C, after which they were
incubated with primary antibody at a concentration of
2-20 g/ml in PBS/BSA/azide for 18-20 hr at 4C in
humidified chambers. For the remaining steps, pre-
fixed sections were treated identically to nonprefixed
sections. Following a PBS/0.1% NaN3 (PBS/azide)
wash, sections were treated with a secondary staining
reagent (5-10/xg/ml) in a similar manner and rinsed
again in PBS/azide at 4C. Samples were then fixed in
2% paraformaldehyde in PBS for 20-30 min., washed
in PBS, and then transferred to 1% H202 in methanol
for 40-50 min to quench endogenous peroxidase
activity. Histochemical detection was carried out
using an avidin-biotin-horseradish peroxidase com-
plex (Vectastain Elite ABC, Vector Laboratories) and
metal-enhanced diaminobenzidine (600 /xg/ml DAB
with 20-30 g/ml 1:1 NiCI2 and CoC12 in 50 mM
Tris-HC1, pH 7.5). Following detection, thymus
sections were counterstained with methyl green and
gut samples with DAPI. Samples were cleared in
xylenes and mounted under coverglasses. For block-
ing experiments, the primary antibody was incubated
with an excess of recombinant mouse IL-2 for at least
12 hr at 4C and potential aggregates were cleared
from the solution by centrifugation before use in
staining.
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